Pembrolizumab
(asked on 7th July 2022) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to make Pembrolizumab available on the NHS for people with tumours.
This question was answered on 18th July 2022
Pembrolizumab is licensed in the treatment of several different types of cancer and has been recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of tumours, such as melanoma and non-small cell lung cancer subject to specified clinical criteria. Pembrolizumab is available to National Health Service patients in England in line with NICE’s recommendations.